Gujarat Kidney And Super Speciality credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026
15.715.7
−40.6−40.6
0.06×0.06×
−0.16×−0.16×
0.58×0.58×
−1.52×−1.51×
11.84×11.84×
5.8%5.8%
As filed — company-reported covenants
—0.06×
—47.93×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GKSL₹171.87

Gujarat Kidney And Super Speciality Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,355 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt15.715.7
Net Debt-40.6-40.6
Total Debt/Equity0.060.06
Net Debt/Equity-0.16-0.16
Total Debt/EBITDA0.580.58
Net Debt/EBITDA-1.51-1.52
Interest Coverage (EBIT/Interest)11.8411.84
Total Debt/Total Capital %5.815.81
As Filed — company-reported covenants
Debt/Equity (as filed)0.06—
Interest Service Coverage (as filed)47.93—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.